GEHC vs. TMO: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at GEHC and TMO, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | GEHC | TMO |
|---|---|---|
| Company Name | GE HealthCare Technologies Inc. | Thermo Fisher Scientific Inc. |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Equipment & Supplies | Life Sciences Tools & Services |
| Market Capitalization | 34.39 billion USD | 183.06 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | December 15, 2022 | March 17, 1980 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of GEHC and TMO by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | GEHC | TMO |
|---|---|---|
| 5-Day Price Return | 5.95% | 6.61% |
| 13-Week Price Return | 1.65% | 12.07% |
| 26-Week Price Return | -14.93% | -15.35% |
| 52-Week Price Return | -8.55% | -19.08% |
| Month-to-Date Return | 5.62% | 3.66% |
| Year-to-Date Return | -3.65% | -6.81% |
| 10-Day Avg. Volume | 4.07M | 2.18M |
| 3-Month Avg. Volume | 4.69M | 2.89M |
| 3-Month Volatility | 28.90% | 37.87% |
| Beta | 1.30 | 0.78 |
Profitability
Return on Equity (TTM)
GEHC
25.15%
Health Care Equipment & Supplies Industry
- Max
- 34.53%
- Q3
- 19.38%
- Median
- 9.52%
- Q1
- 4.86%
- Min
- -7.58%
In the upper quartile for the Health Care Equipment & Supplies industry, GEHC’s Return on Equity of 25.15% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
TMO
13.27%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.55%
- Median
- 6.22%
- Q1
- 3.86%
- Min
- -6.95%
In the upper quartile for the Life Sciences Tools & Services industry, TMO’s Return on Equity of 13.27% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
GEHC
11.23%
Health Care Equipment & Supplies Industry
- Max
- 23.34%
- Q3
- 13.06%
- Median
- 9.53%
- Q1
- 5.96%
- Min
- -3.87%
GEHC’s Net Profit Margin of 11.23% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.
TMO
15.23%
Life Sciences Tools & Services Industry
- Max
- 27.28%
- Q3
- 16.17%
- Median
- 7.24%
- Q1
- 3.00%
- Min
- -3.05%
TMO’s Net Profit Margin of 15.23% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
GEHC
13.82%
Health Care Equipment & Supplies Industry
- Max
- 29.44%
- Q3
- 17.80%
- Median
- 13.95%
- Q1
- 8.73%
- Min
- -3.56%
GEHC’s Operating Profit Margin of 13.82% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
TMO
17.13%
Life Sciences Tools & Services Industry
- Max
- 33.15%
- Q3
- 19.34%
- Median
- 13.02%
- Q1
- 8.05%
- Min
- -4.38%
TMO’s Operating Profit Margin of 17.13% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | GEHC | TMO |
|---|---|---|
| Return on Equity (TTM) | 25.15% | 13.27% |
| Return on Assets (TTM) | 6.59% | 6.62% |
| Net Profit Margin (TTM) | 11.23% | 15.23% |
| Operating Profit Margin (TTM) | 13.82% | 17.13% |
| Gross Profit Margin (TTM) | 41.55% | 41.34% |
Financial Strength
Current Ratio (MRQ)
GEHC
1.16
Health Care Equipment & Supplies Industry
- Max
- 4.90
- Q3
- 3.05
- Median
- 2.14
- Q1
- 1.49
- Min
- 0.86
GEHC’s Current Ratio of 1.16 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
TMO
1.93
Life Sciences Tools & Services Industry
- Max
- 4.76
- Q3
- 2.77
- Median
- 1.85
- Q1
- 1.40
- Min
- 0.43
TMO’s Current Ratio of 1.93 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
GEHC
1.06
Health Care Equipment & Supplies Industry
- Max
- 1.49
- Q3
- 0.71
- Median
- 0.45
- Q1
- 0.14
- Min
- 0.00
GEHC’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 1.06. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
TMO
0.70
Life Sciences Tools & Services Industry
- Max
- 1.75
- Q3
- 0.83
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
TMO’s Debt-to-Equity Ratio of 0.70 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
GEHC
6.19
Health Care Equipment & Supplies Industry
- Max
- 58.29
- Q3
- 25.56
- Median
- 9.06
- Q1
- 3.60
- Min
- -28.92
GEHC’s Interest Coverage Ratio of 6.19 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
TMO
23.55
Life Sciences Tools & Services Industry
- Max
- 29.61
- Q3
- 23.24
- Median
- 6.07
- Q1
- 2.18
- Min
- -14.08
TMO’s Interest Coverage Ratio of 23.55 is in the upper quartile for the Life Sciences Tools & Services industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.
Financial Strength at a Glance
| Symbol | GEHC | TMO |
|---|---|---|
| Current Ratio (MRQ) | 1.16 | 1.93 |
| Quick Ratio (MRQ) | 0.90 | 1.50 |
| Debt-to-Equity Ratio (MRQ) | 1.06 | 0.70 |
| Interest Coverage Ratio (TTM) | 6.19 | 23.55 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
GEHC
0.17%
Health Care Equipment & Supplies Industry
- Max
- 4.05%
- Q3
- 1.76%
- Median
- 0.71%
- Q1
- 0.00%
- Min
- 0.00%
GEHC’s Dividend Yield of 0.17% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.
TMO
0.33%
Life Sciences Tools & Services Industry
- Max
- 1.80%
- Q3
- 0.78%
- Median
- 0.37%
- Q1
- 0.00%
- Min
- 0.00%
TMO’s Dividend Yield of 0.33% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
GEHC
2.63%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 72.47%
- Median
- 27.49%
- Q1
- 0.00%
- Min
- 0.00%
GEHC’s Dividend Payout Ratio of 2.63% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
TMO
9.27%
Life Sciences Tools & Services Industry
- Max
- 156.00%
- Q3
- 65.73%
- Median
- 23.81%
- Q1
- 0.00%
- Min
- 0.00%
TMO’s Dividend Payout Ratio of 9.27% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | GEHC | TMO |
|---|---|---|
| Dividend Yield (TTM) | 0.17% | 0.33% |
| Dividend Payout Ratio (TTM) | 2.63% | 9.27% |
Valuation
Price-to-Earnings Ratio (TTM)
GEHC
15.34
Health Care Equipment & Supplies Industry
- Max
- 73.48
- Q3
- 51.69
- Median
- 34.31
- Q1
- 25.74
- Min
- 11.47
In the lower quartile for the Health Care Equipment & Supplies industry, GEHC’s P/E Ratio of 15.34 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
TMO
27.78
Life Sciences Tools & Services Industry
- Max
- 117.96
- Q3
- 65.59
- Median
- 37.26
- Q1
- 27.51
- Min
- 1.73
TMO’s P/E Ratio of 27.78 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
GEHC
1.72
Health Care Equipment & Supplies Industry
- Max
- 9.53
- Q3
- 5.26
- Median
- 3.39
- Q1
- 2.13
- Min
- 0.00
In the lower quartile for the Health Care Equipment & Supplies industry, GEHC’s P/S Ratio of 1.72 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
TMO
4.23
Life Sciences Tools & Services Industry
- Max
- 12.46
- Q3
- 6.70
- Median
- 4.24
- Q1
- 2.68
- Min
- 0.73
TMO’s P/S Ratio of 4.23 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
GEHC
3.49
Health Care Equipment & Supplies Industry
- Max
- 10.85
- Q3
- 5.98
- Median
- 3.48
- Q1
- 2.43
- Min
- 0.69
GEHC’s P/B Ratio of 3.49 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
TMO
3.03
Life Sciences Tools & Services Industry
- Max
- 7.99
- Q3
- 4.69
- Median
- 3.30
- Q1
- 1.88
- Min
- 1.02
TMO’s P/B Ratio of 3.03 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | GEHC | TMO |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 15.34 | 27.78 |
| Price-to-Sales Ratio (TTM) | 1.72 | 4.23 |
| Price-to-Book Ratio (MRQ) | 3.49 | 3.03 |
| Price-to-Free Cash Flow Ratio (TTM) | 21.98 | 29.63 |